Patents Represented by Attorney Carissa A. Tener
  • Patent number: 7485324
    Abstract: The administration of gaseous nitric oxide as a biocidal moiety is proffered as a de novo treatment in the control and eradication of biofilms. The present invention relates to the use or methods of application of exogenous nitric oxide gas (gNO) as a stand alone biocidal agent or in cohort with any or all adjunct vehicles in the control of biofilms generated by microbial organisms, i.e., bacteria, protozoa, amoeba, fungi etc. Further, the present invention introduces the concept of utilization and methods of application of gaseous nitric oxide in control and eradication of biofilm forming microorganisms. Noteworthy areas of application are offered as examples. They include, and are not limited to, air and/or water heating/cooling distribution systems in facilities such as hospitals and laboratories, surfaces of medical devices, household surfaces, dental plaque, dental and/or medical water treatment lines, industrial pipelines, water treatment and distribution facilities and fluids sterilization.
    Type: Grant
    Filed: September 29, 2004
    Date of Patent: February 3, 2009
    Assignee: Pulmonox Technologies Corporation
    Inventors: Chris Miller, Abdi Ghaffari, Ali Ardakani, Bruce Murray, Doug Hole
  • Patent number: 7335181
    Abstract: A method of topically treating the respiratory tract of a mammal with nitric oxide exposure includes the steps of providing a source of nitric oxide containing gas and delivering the nitric oxide containing gas nasally to the upper respiratory tract of the mammal. Also provided are several designs for a nasal delivery device for the controlled nasal deliver the nitric oxide containing gas.
    Type: Grant
    Filed: April 14, 2005
    Date of Patent: February 26, 2008
    Assignees: Pulmonox Technologies Corporation, Sensormedics Corporation
    Inventors: Christopher Miller, Alex Stenzler